Cytokine production by human leukocytes with different expressions of natural antiviral immunity and the effect of antibodies against interferons and TNF-α

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 2, 2007, Pages 111-117

  Orzechowska, Beata ^a   Antoszków, Zenon ^a   Siemieniec, Iwona ^a   Lorenc, Maria ^a   Jatczak, Bogna ^a   Błach Olszewska, Zofia ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cytokines; Innate immunity; Leukocytes; Viral infection

Indexed keywords

ANTIBODY; BETA INTERFERON; CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CELL ISOLATION; CENTRIFUGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKOCYTE; STATISTICAL SIGNIFICANCE; TITRIMETRY; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CYTOKINES; HUMANS; IMMUNITY, NATURAL; INTERFERONS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES; MIDDLE AGED; RHABDOVIRIDAE INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 34147115141     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0013-y     Document Type: Article

References (29)

1. Baccala R., Kono D. H. and Theofilopoulos A. N. (2005): Interferons as pathogenic effectors in autoimmunity. Immunol. Rev., 204, 9-26.
2. Błach-Olszewska Z. (2005): Innate immunity: cells, receptors and signaling pathway. Arch. Immunol. Ther. Exp., 53, 245-253.
3. Błach-Olszewska Z. (2006): Mechanizmy kontroli odpornooeci wrodzonej [Control of over-activated innate immunity]. Postȩpy Hig. Med. Dooew., 60, 201-208.
4. Błach-Olszewska Z., Zaczyñska E., Kiełbiñski M. and Frydecka I. (2005): Deficiency of innate immunity of leukocytes is associated with the failure of the induction of remission and survival time in patients with acute leukemia. Pol. J. Environmental Studies, 14 (suppl. II), 36-40.
5. Domaraczenko B., Janusz M., Orzechowska B., Jarosz W. and Błach-Olszewska Z. (1999): Effect of proline rich polypeptide from ovine colostrum on virus replication in human placenta and amniotic membrane at term; possible role of endogenous tumor necrosis factor. Placenta, 20, 695-701.
6. Ferlazzo G. and Munz C. (2004): NK cell compartments and their activation by dendritic cells. J. Immunol., 172, 133.3-1339.
7. Flick D. A. and Gifford G. E. (1984): Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods, 68, 167-171.
8. Fujita T., Matsushita M. and Endo Y. (2004): The lectin-complement pathway - its role in innate immunity and evolution. Immunol. Rev., 198, 185-202.
9. Jatczak B., Gejdel E., Paja̧k J., Podwiñska J. and Błach-Olszewska Z. (2001): Study on risk factors for transplacental viral infections; effect of bacterial factors and double viral infections on virus replication in placenta and amniotic membranes. Placenta, 22, 360-371.
10. Jones S. A. (2005): Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol., 175, 3463-3468.
11. Lane B. R., Markovitz D. M., Woodford N. L., Rochford R., Strieter R. M. and Coffey M. J. (1999): TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol., 163, 3653-3661.
12. Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J. and Vartanian T. (2003): Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA, 100, 8514-8519
13. Mestan J., Digel W., Mittnacht S., Hillen H., Blohm D., Moller A., Jacobsen H. and Kirchner H. (1986): Antiviral effect of recombinant tumour necrosis factor in vitro. Nature, 323, 816-819.
14. Miedzhitow R. and Biron C. A. (2003): Innate immunity. Curr. Opin. Immunol., 15, 2-4.
15. Murray P. J. (2005): The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA, 102, 8686-8691.
16. Orzechowska B., Antoszków Z., Siemieniec I. and Błach-Olszewska Z. (2003): Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumour necrosis factor in the immunity of leukocytes Arch. Immunol. Ther. Exp., 51, 51-60.
17. Paradowska E., Błach-Olszewska Z., Gierliñska M. and Woytoñ J. (1996): Effect of exogenous tumor necrosis factor, interleukin 6, and interferons on vesicular stomatitis virus replication in human placenta and amniotic membrane organ cultures. Arch. Immunol. Ther. Exp., 44, 57-62.
18. Paradowska E., Błach-Olszewska Z., Sender J. and Jarosz W. (1996): Antiviral nonspecific immunity. Possible role of endogenous tumor necrosis factor and interferons. J. Interferon Cytokines Res., 16, 941-947.
19. Poea-Guyon S., Christadoss P., Le Panse R., Guyon T., De Baets M., Wakkach A., Bidault J., Tzartos S. and Berrih-Aknin S. (2005): Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J. Immunol., 174, 5941-5949.
20. Rifkin I. R., Leadbetter E. A., Busconi L., Viglianti G. and Marshak-Rothstein A. (2005): Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev., 204, 27-42.
21. Rybka K., Orzechowska B., Siemieniec I., Leszek J., Zaczyñska E., Paja̧k J. and Błach-Olszewska Z. (2003): Age related natural antiviral non-specific immunity of human leukocytes. Med. Sci. Monit., 9, BR413-417.
22. Selander B., Martensson U., Weintraub A., Holmstrom E., Matsushita M., Thiel S., Jensenius J. C., Truedsson L. and Sjoholm A. G. (2006): Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J. Clin. Invest., 116, 1425-1434.
23. Tanga F. Y., Nutile-McMenemy N. and DeLeo J. A. (2005): The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. USA, 102, 5856-5861.
24. Townsend K. P., Town T., Mori T., Lue L. F., Shytle D., Sanberg P.R., Morgan D., Fernandez F., Flavell R. A. and Tan J. (2005): CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β-peptide. Eur. J. Immunol., 35, 901-910.
25. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA, 83, 9679-9683.
26. Wong G. H., Kamb A. and Goeddel D. V. (1992): Antiviral properties of TNF. In Buetler B (ed.): Tumor necrosis factor: the molecules and their emerging role in medicine. Raven Press Ltd., New York, pp. 371-382.
27. Yuste J., Ali S., Sriskadan S., Hyams C., Botto M. and Brown J. S. (2006): Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes. J. Immunol., 176, 6112-6120.
28. Zaczyñska E. and Błach-Olszewska Z. (2001): Effect of cyclosporine A on the non-specific innate immunity of mice. Arch. Immunol Ther Exp., 49 (suppl.), S53-S57.
29. Zaczyñska E., Błach-Olszewska Z. and Gejdel E. (1995): Production of cytokines with antiviral activity by endothelial cells. J. Interferon Cytokine Res., 15, 811-814.